AbbVie Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . AbbVie Inc
ABBV Stock  USD 175.65  0.39  0.22%   
AbbVie financial statements provide useful quarterly and yearly information to potential AbbVie Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on AbbVie financial statements helps investors assess AbbVie's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AbbVie's valuation are summarized below:
Gross Profit
39.1 B
Profit Margin
0.0922
Market Capitalization
309.7 B
Enterprise Value Revenue
6.7258
Revenue
55.5 B
There are over one hundred nineteen available fundamental signals for AbbVie Inc, which can be analyzed over time and compared to other ratios. All traders should should validate AbbVie's prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable.

AbbVie Total Revenue

33.85 Billion

Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.5 B, Interest Expense of 2.7 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

AbbVie Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding1.8 B2 B1.7 B
Slightly volatile
Total Assets81.2 B154.9 B79.4 B
Slightly volatile
Other Current Liabilities32.6 B31 B13.8 B
Slightly volatile
Total Current Liabilities45.7 B43.5 B20.3 B
Slightly volatile
Other Liabilities38.3 B36.5 B17.9 B
Slightly volatile
Property Plant And Equipment Net3.6 B5.7 B3.4 B
Slightly volatile
Accounts Payable4.5 B4.2 B1.9 B
Slightly volatile
Cash10.5 B14.7 B10 B
Slightly volatile
Non Current Assets Total122.8 B117 B60.9 B
Slightly volatile
Other Assets5.8 B5.6 B2.6 B
Slightly volatile
Cash And Short Term Investments11 B14.7 B10.3 B
Slightly volatile
Net Receivables6.8 B12.8 B6.7 B
Slightly volatile
Good Will39 B37.1 B19.5 B
Slightly volatile
Liabilities And Stockholders Equity81.2 B154.9 B79.4 B
Slightly volatile
Non Current Liabilities Total55.5 B99.4 B53.9 B
Slightly volatile
Inventory4.9 B4.7 B2.3 B
Slightly volatile
Other Current Assets3.5 B5.7 B3.3 B
Slightly volatile
Total Liabilities74.1 B143 B72.5 B
Slightly volatile
Property Plant And Equipment Gross14 B13.4 B5.7 B
Slightly volatile
Total Current Assets23.5 B38 B22.5 B
Slightly volatile
Intangible Assets32.2 B64 B31.7 B
Slightly volatile
Property Plant Equipment3.4 B5.7 B3.4 B
Slightly volatile
Long Term Debt41.2 B60 B36.8 B
Slightly volatile
Short and Long Term Debt Total49.8 B68.3 B43.3 B
Slightly volatile
Non Currrent Assets Other10.3 B9.8 B3.4 B
Slightly volatile
Common Stock Total Equity15.4 M16.2 M710.2 M
Slightly volatile
Short Term Debt5.2 B8.3 B4.5 B
Slightly volatile
Common Stock15.4 M16.2 M710.2 M
Slightly volatile
Long Term Debt Total50.1 B68 B41.2 B
Slightly volatile
Capital Surpluse15.8 B22.1 B13.2 B
Slightly volatile
Long Term Investments498.6 M273.6 M498.9 M
Very volatile
Non Current Liabilities Other19.7 B32.9 B15.4 B
Slightly volatile
Short and Long Term Debt6 B8.3 B5.3 B
Slightly volatile
Net Invested Capital74.5 B80.2 B57.9 B
Slightly volatile
Capital Stock14.4 M16.2 M17.7 M
Slightly volatile

AbbVie Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10.5 B10 B3.6 B
Slightly volatile
Selling General Administrative7.8 B12.3 B7.7 B
Slightly volatile
Total Revenue33.8 B62.5 B33.9 B
Slightly volatile
Gross Profit24.3 B39 B24 B
Slightly volatile
Other Operating Expenses50.2 B47.8 B25.7 B
Slightly volatile
Operating Income9.8 B14.7 B9.6 B
Slightly volatile
EBIT10.7 B9.9 B10.1 B
Slightly volatile
Research Development5.5 B9.7 B5.5 B
Slightly volatile
EBITDA13.5 B19.9 B13.2 B
Slightly volatile
Cost Of Revenue24.7 B23.5 B10.8 B
Slightly volatile
Total Operating Expenses14 B24.3 B13.9 B
Slightly volatile
Income Before Tax7.3 B7.2 B6.8 B
Slightly volatile
Net Income6.3 B5.6 B5.9 B
Slightly volatile
Net Income Applicable To Common Shares14.3 B13.6 B7.3 B
Slightly volatile
Net Income From Continuing Ops6.9 B5.6 B5.9 B
Slightly volatile
Non Recurring553.6 M801.5 M506.2 M
Slightly volatile
Interest Income510.3 M486 M494.8 M
Slightly volatile
Reconciled Depreciation5.9 B10 B4 B
Slightly volatile
Selling And Marketing Expenses2 B2.5 B1.5 B
Slightly volatile

AbbVie Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation902 M859 M464.7 M
Slightly volatile
Free Cash Flow26.6 B25.4 B13.2 B
Slightly volatile
Begin Period Cash Flow8.9 B10.6 B8.8 B
Slightly volatile
Depreciation10.5 B10 B4 B
Slightly volatile
Capital Expenditures611.5 M893.5 M587.3 M
Slightly volatile
Total Cash From Operating Activities27.6 B26.3 B13.8 B
Slightly volatile
Net Income6.3 B5.6 B5.9 B
Slightly volatile
End Period Cash Flow9.8 B14.7 B9.9 B
Slightly volatile
Change To Netincome3.4 B3 B2.6 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.394.544.2399
Pretty Stable
Dividend Yield0.02890.03460.0345
Slightly volatile
Days Sales Outstanding79.7586.273.8096
Pretty Stable
Free Cash Flow Yield0.0650.07250.0798
Very volatile
Operating Cash Flow Per Share12.2111.637.7856
Slightly volatile
Stock Based Compensation To Revenue0.00980.01240.0122
Slightly volatile
Capex To Depreciation0.09760.10.3097
Slightly volatile
EV To Sales4.025.314.9845
Slightly volatile
Free Cash Flow Per Share11.7911.237.4335
Slightly volatile
ROIC0.170.110.1519
Slightly volatile
Inventory Turnover3.584.484.4122
Very volatile
Net Income Per Share2.82.483.4517
Slightly volatile
Days Of Inventory On Hand92.9184.2884.9798
Pretty Stable
Payables Turnover6.726.376.1603
Slightly volatile
Sales General And Administrative To Revenue0.280.230.2484
Slightly volatile
Research And Ddevelopement To Revenue0.140.15560.1624
Very volatile
Capex To Revenue0.0220.01650.0194
Slightly volatile
Cash Per Share5.06.526.1888
Slightly volatile
POCF Ratio13.8913.812.8651
Very volatile
Interest Coverage6.276.618.5242
Slightly volatile
Payout Ratio2.051.951.0808
Slightly volatile
Capex To Operating Cash Flow0.06830.03910.0593
Slightly volatile
PFCF Ratio15.0414.2813.8664
Very volatile
Days Payables Outstanding55.959.3468.3345
Very volatile
Income Quality4.434.222.3434
Slightly volatile
EV To Operating Cash Flow11.9812.6314.6413
Very volatile
PE Ratio53.2450.7129.2781
Slightly volatile
Return On Tangible Assets0.110.120.2161
Slightly volatile
EV To Free Cash Flow17.7916.7116.3087
Very volatile
Earnings Yield0.01940.02040.0454
Slightly volatile
Intangibles To Total Assets0.430.590.5374
Slightly volatile
Current Ratio1.711.01.5297
Slightly volatile
Receivables Turnover4.094.385.0025
Pretty Stable
Graham Number15.9717.1419.5374
Slightly volatile
Capex Per Share0.270.40.3427
Slightly volatile
Revenue Per Share14.927.6519.5083
Slightly volatile
Interest Debt Per Share20.8931.3624.4854
Slightly volatile
Debt To Assets0.420.40.4722
Slightly volatile
Enterprise Value Over EBITDA10.0216.6712.6348
Pretty Stable
Short Term Coverage Ratios3.473.6553.1728
Slightly volatile
Price Earnings Ratio53.2450.7129.2781
Slightly volatile
Operating Cycle173170159
Pretty Stable
Days Of Payables Outstanding55.959.3468.3345
Very volatile
Dividend Payout Ratio2.051.951.0808
Slightly volatile
Price To Operating Cash Flows Ratio13.8913.812.8651
Very volatile
Price To Free Cash Flows Ratio15.0414.2813.8664
Very volatile
Pretax Profit Margin0.260.130.2293
Slightly volatile
Ebt Per Ebit0.880.560.776
Slightly volatile
Operating Profit Margin0.320.270.2943
Very volatile
Effective Tax Rate0.140.20.1835
Very volatile
Long Term Debt To Capitalization0.660.750.7633
Slightly volatile
Total Debt To Capitalization0.670.770.7708
Slightly volatile
Return On Capital Employed0.220.150.1938
Slightly volatile
Ebit Per Revenue0.320.270.2943
Very volatile
Quick Ratio1.560.881.3977
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.22.325.0009
Slightly volatile
Net Income Per E B T0.70.77810.8568
Very volatile
Cash Ratio0.520.30.6177
Very volatile
Cash Conversion Cycle95.8194.6588.1149
Slightly volatile
Operating Cash Flow Sales Ratio0.280.380.3537
Slightly volatile
Days Of Inventory Outstanding92.9184.2884.9798
Pretty Stable
Days Of Sales Outstanding79.7586.273.8096
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.750.870.9237
Pretty Stable
Cash Flow Coverage Ratios0.420.4416.5454
Slightly volatile
Fixed Asset Turnover7.69.89.3969
Slightly volatile
Capital Expenditure Coverage Ratio15.6126.4520.2224
Slightly volatile
Price Cash Flow Ratio13.8913.812.8651
Very volatile
Enterprise Value Multiple10.0216.6712.6348
Pretty Stable
Debt Ratio0.420.40.4722
Slightly volatile
Cash Flow To Debt Ratio0.420.4416.5454
Slightly volatile
Price Sales Ratio3.394.544.2399
Pretty Stable
Return On Assets0.03940.04150.0958
Slightly volatile
Asset Turnover0.570.460.5228
Slightly volatile
Net Profit Margin0.09780.10.1857
Slightly volatile
Gross Profit Margin0.80.720.7377
Slightly volatile

AbbVie Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap74 B118 B112.3 B
Slightly volatile
Enterprise Value50.9 B57.3 B62.4 B
Slightly volatile

AbbVie Fundamental Market Drivers

Forward Price Earnings14.6199
Cash And Short Term Investments12.8 B

AbbVie Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.3 B-3.5 B
Total Revenue62.5 B33.8 B
Cost Of Revenue23.5 B24.7 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.23  0.28 
Research And Ddevelopement To Revenue 0.16  0.14 
Capex To Revenue 0.02  0.02 
Revenue Per Share 27.65  14.90 
Ebit Per Revenue 0.27  0.32 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY